The Centre for Chemical Biology (CCB) is committed to providing innovative therapeutics for the treatment of human disease.
By bringing together research teams of international excellence from chemistry, biology and medicine The Centre will focus on unraveling the causes of disease, identifying crucial biological targets and will pioneer the rapid development of novel drugs for the fight against disease.
Funding for New Centre to Propel Australia to Forefront of Cancer Research
Children’s Medical Research Institute (CMRI) and the University of Newcastle (UoN) are pleased to announce they have received funding to establish the Australian Cancer Research Foundation Centre for Kinomics (ACRF-CFK) - an Australian-first that will provide an entirely new approach to the understanding of cancer therapeutic drugs and ways to improve them.
This significant, non-commercial initiative builds upon demonstrated research excellence, leadership and successful collaborations between scientists from CMRI and UoN. The ACRF-CFK will be equipped with state-of-the-art instrumentation, thanks to generous funding from the Australian Cancer Research Foundation (ACRF) who provided a $3.1 million grant, supplemented with additional funding of $1 million from the Ramaciotti Foundation
International alliance delivers treasure trove of data
Associate Professor Peter Lewis and his research group are the only Australian members of the international team, which has developed a complete understanding of the consequences of changes in a cell during disease development. The findings of the Bacillus Systems Biology (BaSysBio) project, will ultimately lead to the development of new drugs to protect people against antibiotic resistant infections, including golden staph.
Associate Professor Lewis received $486,000 from the National Health and Medical Research Council and $110,000 from the Australian Government Department of Education, Science and Training for his team’s part in the project.
CCB Partnership with Invasive Animal CRC Funded
On 22nd November 2011 the Minister for Innovation Senator Kim Carr announced the successful rebid by the Invasive Animals CRC for funding until 2017.
PRCCB team Prof Eileen McLaughlin, Dr Shaun Roman and Prof Adam McCluskey are integral to the design and testing of key technologies to reduce the impacts of new and existing pest animals on Australia’s agricultural competitiveness and biodiversity assets and will benefit from $19.7 million awarded to the IACRC.